Related Experiment Video
Updated: Jul 14, 2026
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
A reverse transcriptase assay for early diagnosis of infant HIV infection in resource-limited settings
Sumathi Sivapalasingam1, Usha Patel, Vincenza Itri
1Department of Medicine, Division of Infectious Diseases, New York University School of Medicine New York, NY 10016, USA. sumathi.sivapalasingam@gmail.com
Insights
A new, low-cost reverse transcriptase (RT) assay shows promise for diagnosing pediatric HIV-1 infection in infants. This affordable test could improve early detection in resource-limited settings, overcoming challenges posed by maternal antibodies.
Area of Science:
- Pediatric Infectious Diseases
- Virology
- Diagnostic Assay Development
Background:
- Early diagnosis of pediatric Human Immunodeficiency Virus type 1 (HIV-1) infection is critical but challenging due to persistent maternal antibodies up to 18 months.
- Current diagnostic methods like HIV-1 DNA PCR are often too expensive for resource-limited settings.
Purpose of the Study:
- To evaluate a low-cost, commercial reverse transcriptase (RT) assay for diagnosing HIV-1 infection in infants.
- To assess the feasibility of this assay in resource-limited environments.
Main Methods:
- RT assays were performed on 42 samples from 30 HIV-exposed Kenyan infants under 15 months of age.
- Results were correlated with serologic testing performed after 18 months of age.
Main Results:
- The RT assay demonstrated high performance metrics: 92% sensitivity, 93% specificity, 87% positive predictive value, and 96% negative predictive value.
- These results indicate the assay's potential for accurate HIV-1 diagnosis in infants.
Conclusions:
- The evaluated low-cost RT assay is a viable option for diagnosing HIV-1 infection in infants.
- Further evaluation is warranted to establish this assay as a crucial tool for early pediatric HIV diagnosis, especially in resource-limited settings.
Abstract:
Early diagnosis of pediatric HIV infection is confounded by persistence of maternal antibodies until 18 months, necessitating the use of expensive assays such as HIV-1 DNA PCR, an untenable option in resource-limited settings. This is the first report of a low-cost, commercial, reverse transcriptase (RT) assay for the diagnosis of HIV-1 infection in infants. RT assays were performed on 42 samples from 30 HIV-exposed Kenyan infants under 15 months of age. When correlated with serologic testing conducted after 18 months, the sensitivity, specificity, positive and negative predictive values of the RT assay were 92%, 93%, 87% and 96%. A low-cost assay for infant HIV diagnosis is urgently needed, and these results merit further evaluation.
